Ruthenium-based complexes have received much interest as potential metallodrugs. In this work, four RuII complexes bearing a dicarbollide moiety, a carbonyl ligand, and a phenanthroline-based ligand were synthesized and characterized, including single crystal diffraction analysis of compounds 2, 4, and 5 and an observed side product SP1. Complexes 2–5 are air and moisture stable under ambient conditions. They show excellent solubility in organic solvents, but low solubility in water.

No description available.

The two projects described in this dissertation demonstrate the wide utility of noble metal N-heterocyclic carbene (NHC) complexes. The first project details the design of iridium NHC amino acid complexes for asymmetric transfer hydrogenation (ATH) of prochiral ketones. Iridium(I) bis-NHC complexes were found to undergo oxidative addition with a variety of alpha-amino acids, generating chiral iridium(III) complexes of the form Ir(NHC)2(aa)(H)(X) (aa = amino acid, X = halide). The complexes were screened for ATH of aryl and alkyl ketones, and optimization studies found enantioselectivity in this system was highly sensitive to the reaction temperature, NHC ligand, and amino acid. Incorporation of secondary amino acids was essential to enantioselectivity. Aryl ketones were reduced in high conversion and enantioselectivity when employing the Ir(IMe)2(L-Pro)(H)(I) catalyst in isopropyl alcohol, in some cases giving over 90% ee of the alcohol products. Density functional theory calculations were conducted in order to gain insight into the active catalytic species, and the results suggest that the high enantioselectivity of this system primarily arises from steric effects. The second project details the design of rhodium and iridium NHC piano-stool complexes featuring derivatized tetramethylcyclopentadienyl ligands (Cp*R, R = alkyl or aryl substituent) for antimicrobial applications. Complexes of the form (Cp*R)M(NHC)Cl2 (M = Rh or Ir) were synthesized by transmetallation of the NHC ligand using silver(I) oxide in the presence of the desired noble metal Cp*R dimer. The complexes were screened for biological activity against various bacteria, yeast, and fungi. Many of these compounds were highly active against Mycobacterium smegmatis, displaying minimum inhibitory concentrations (MICs) as low at 0.25 microgram per mL. Analysis of structure-activity relationships found that incorporation of the NHC ligand greatly enhances the antimicrobial properties of rhodium and iridium piano-stool complexes, more so than previously investigated diamine, amino acid, or beta-diketonato ligands. Cytotoxicity studies on one of the rhodium NHC complexes showed this compound was nontoxic towards mammalian cells at low concentrations, which strengthens the potential of these types of compounds as viable drug candidates. / Doctor of Philosophy / This dissertation describes two practical applications of a series of complexes featuring the noble metals rhodium and iridium. In all of these complexes, the metal center is bonded to one or two groups known as N-heterocyclic carbenes (NHCs). The most common structural variant of NHCs are five-membered rings. The metal is usually bonded to a carbon atom on these rings, which is flanked by two nitrogen atoms. Noble metal complexes containing NHCs are widely investigated in contemporary chemical literature for a variety of reactions, primarily because noble metals form exceptionally strong bonds with NHCs, making these complexes very stable. N-Heterocyclic carbene compounds are also fairly easy to synthesize and structurally modify, which allows fine-tuning for specific applications. The first project in this dissertation employed iridium NHC amino acid complexes for the selective production of alcohols, meaning only one structure of the alcohol product is favorably generated. This is an important transformation in the chemical and pharmaceutical industries, which often require the synthesis of highly pure products. These complexes were found to be quite successful for this application on a range of model substrates, in some cases generating as high as 95% of one alcohol product over the other. Product selectivity was found to depend on the specific structure of the NHC compound. The second project investigated the antimicrobial properties of rhodium and iridium NHC complexes. In recent years, the growing threat of antimicrobial resistance against traditional pharmaceuticals has led to an interest in the development of metal-based drugs, which may allow for metal-specific mechanisms of drug action that are not possible for commonly employed antimicrobial agents. These NHC complexes were screened for biological activity against various bacteria, yeast, and fungi. Many of the complexes displayed high activity against Mycobacterium smegmatis, comparable to those displayed by other clinical drugs such as ampicillin or streptomycin. These results were highly encouraging, as Mycobacterium smegmatis often serves as a model to study other mycobacteria.

No description available.

L'enveloppe cellulaire des bactéries à Gram négatif constitue la première ligne de défense contre les antibiotiques. Sous l’effet, d’une part, de la faible perméabilité de la membrane externe qui s'oppose à la pénétration des agents antibactériens, d’autre part des pompes d'efflux qui favorisent leur expulsion, elle empêche nombre de composés potentiellement actifs in vitro d'atteindre leur cible, limitant l’effet antibactérien. Un enjeu important pour restaurer l’activité de ces molécules est de trouver une stratégie pour en augmenter la concentration intracellulaire. L'objectif de cette thèse est de développer des métallodrogues comme nouvelle stratégie de vectorisation de drogues dans les cellules. Cette stratégie repose sur l’association d'une drogue active in vitro, et d’un ligand auxiliaire ayant des propriétés perméabilisantes ou inhibitrices de pompe d’efflux, dans un complexe qui jouera le rôle de chaperone. Les agents antibactériens utilisés sont des inhibiteurs (dérivés d’acides hydroxamiques) de peptide déformylase (PDF) et de méthionine aminopeptidase (MetAP) développés au laboratoire. Tout d’abord, une étude globale de la stratégie de vectorisation a été réalisée (i) étude de stabilité de métallodrogues modèles : en utilisant un acide hydroxamique fluorescent, nous avons montré que, seules, des métallodrogues à Co(III), à la différence de celles à Cu(II) et Fe(III), satisfaisaient aux conditions de stabilité compatibles avec les conditions de tests biologiques. (ii) Etude de la libération de la drogue : nous avons établi par une étude RMN 1H et UV-vis qu’en milieu tampon pH = 7,4, la libération de la drogue se faisait par échange de ligand avec un thiol exogène. Récemment, une nouvelle série d’inhibiteurs de PDF a été synthétisée au laboratoire. Elle est basée sur un squelette hétérocyclique à 5 chaînons fonctionnalisé par une chaîne en C4, puis via un espaceur monocarboné, à un acide hydroxamique. Les meilleurs résultats ont été obtenus avec un oxadiazole (AT002 16 µg/ml sur E. coli en présence de perméabilisant PMBN). Au cours de cette thèse, pour améliorer la lipophilie, des groupements aromatiques ont été fixés sur cet hétérocycle. Les MICs sur la souche d’E. coli sauvage n’ont pas été améliorées mais en présence de PMBN, le dérivé présentant la meilleure activité est le composé AT015 (2 µg/ml sur E. coli en présence de PMBN) qui a donc été choisi pour concevoir des métallodrogues. La métallodrogue réunit autour d’un métal deux parties: (i) un ligand auxiliaire fonctionnalisé via un espaceur par un perméabilisant peptidique analogue de peptide antimicrobien ou par un modulateur de l’efflux (ii) un acide hydroxamique inhibiteur de PDF. Au cours de la SAR réalisée en faisant varier la drogue, le ligand auxiliaire et le métal, nous avons montré que les meilleures métallodrogues permettent d’améliorer l’activité de la drogue sur la souche d’E. coli sauvage d’un facteur 16. Un des ligands auxiliaires fonctionnalisé par un tétrapeptide présente, seul, une activité sur une souche d’E. aerogenes résistante aux fluoroquinolones. Sur ce cas, l’activité biologique a été reliée, par des expériences de mapping par fluorescence, à son accumulation intracellulaire, en utilisant un analogue fluorescent de ce composé. / The gram negative bacterias’ cell envelopes are the first line of defense against antibiotics. First thanks to the low permeability of the external membrane that prevents the penetration of the antibiotics, but also thanks to the efflux pumps that help expelling the antibiotics from the cell. These mechanisms prevent many compounds, potentially active in vitro, from reaching their targets, thus limiting the antimicrobial effect. To increase the molecules’ intracellular concentration is one of the means to restore their activity. This thesis’ objective is to develop metallodrugs as a new drug vectorization strategy in cells. We here associate an active drug in vitro and an auxiliary ligand with permeabilization or efflux pumps inhibition abilities in a complex playing the role of a chaperone. We used peptide deformylase (PDF) and methionine aminopeptidase (MetAP) inhibitors (derived from hydroxamic acids) developed at the laboratory as antimicrobial agents. I’ll begin with a global study of the vectorization strategy we’ve adopted (i) Stability study of the metallodrugs models: using a fluorescent hydroxamic acid, we showed that only Co(III) metallodrugs are in agreement with the stability conditions compatible with the biological tests, in opposition with the Cu(II) and Fe(III) ones. (ii) Drug release study: we showed in 1H NMR and UV-vis studies that in a buffer solution pH 7.4, a ligand exchange with an exogenous thiol is responsible for the drug release. Recently, a new series of PDF inhibitors was synthesized at the laboratory. It is composed of a 5 membered heterocyclic skeleton functionalized by a chain in C4 followed by an hydroxamic acid via a monocarbonated spacer. The best results were obtained with an oxadiazole (AT002 16 µg/ml with E. coli and PMBN as permeabilizing agent). During this thesis, to enhance lipophilicity, we attached aromatic groups on the heterocycle. CMIs on the E. coli strain have not been increased but the compounds displaying the best activity in presence of PMBN (AT015, 2 µg/ml with E. coli and PMBN) was chosen to conceive metallodrugs. The metallodrug is composed of a metal center and two other parts: (i) an auxiliary ligand functionalized via a spacer by a permeabilizing peptide, an antimicrobial peptide analogue, or by an efflux modulator. (ii) An hydroxamic acid PDF inhibitor. We showed that the best metallodrugs enhance the drug activity on the wild E.coli strain by a 16 factor, with the SAR we realized, changing the drug, the auxiliary ligand and the metal. One of the auxiliary ligands functionalized by a tetrapeptide show an activity on a fluoroquinolone-resistant E. aerogenes strain while alone. Utilizing a fluorescent analogous of this compound, we linked the biological activity to its intracellular accumulation with fluorescence mapping experiments.